...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
【24h】

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

机译:含氮的双膦酸盐抑制甲羟戊酸途径,并防止包括Ras在内的GTP结合蛋白的翻译后异戊二烯化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Bisphosphonates are currently the most important class of antiresorptive drugs used for the treatment of metabolic bone diseases. Although the molecular targets of bisphosphonates have not been identified, these compounds inhibit bone resorption by mechanisms that can lead to osteoclast apoptosis. Bisphosphonates also induce apoptosis in mouse J774 macrophages in vitro, probably by the same mechanisms that lead to osteoclast apoptosis. We have found that, in J774 macrophages, nitrogen-containing bisphosphonates (such as alendronate, ibandronate, and risedronate) inhibit post-translational modification (prenylation) of proteins, including the GTP-binding protein Ras, with farnesyl or geranylgeranyl isoprenoid groups. Clodronate did not inhibit protein prenylation. Mevastatin, an inhibitor of 3-hydroxy-3-methylglutatyl (HMG)-CoA reductase and hence the biosynthetic pathway required for the production of farnesyl pyrophosphate and geranylgeranyl pyrophosphate, also caused apoptosis in J774 macrophages and murine osteoclasts in vitro. Furthermore, alendronate-induced apoptosis, like mevastatin-induced apoptosis, could be suppressed in J774 cells by the addition of farnesyl pyrophosphate or geranylgeranyl pyrophosphate, while the effect of alendronate on osteoclast number and bone resorption in murine calvariae in vitro could be overcome by the addition of mevalonic acid. These observations suggest that nitrogen-containing bisphosphonate drugs cause apoptosis following inhibition of post-translational prenylation of proteins such as Ras. It is likely that these potent antiresorptive bisphosphonates also inhibit bone resorption by preventing protein prenylation in osteoclasts and that enzymes of the mevalonate pathway or prenyl protein transferases are the molecular targets of the nitrogen-containing bisphosphonates. Furthermore, the data support the view that clodronate acts by a different mechanism.
机译:目前,双膦酸盐类是用于治疗代谢性骨病的最重要的抗吸收药物。尽管尚未确定双膦酸酯的分子靶标,但这些化合物通过可能导致破骨细胞凋亡的机制抑制骨吸收。双膦酸盐也可能在体外诱导小鼠J774巨噬细胞凋亡,其机制可能与破骨细胞凋亡相同。我们发现,在J774巨噬细胞中,含氮的双膦酸酯(例如阿仑膦酸酯,伊班膦酸酯和利塞膦酸酯)会抑制蛋白质(包括GTP结合蛋白Ras)具有法呢基或香叶基香叶基类异戊二烯基团的翻译后修饰(异戊二烯化)。氯膦酸盐不抑制蛋白质异戊二烯化。美伐他汀是3-羟基-3-甲基谷氨酰(HMG)-CoA还原酶的抑制剂,因此是法呢基焦磷酸和香叶基香叶基焦磷酸的产生所需的生物合成途径,也引起J774巨噬细胞和鼠破骨细胞的凋亡。此外,通过加入法呢基焦磷酸酯或香叶基香叶基Geranyl焦磷酸酯,可以抑制J774细胞中阿仑膦酸盐诱导的凋亡(如美伐他汀诱导的凋亡),而阿仑膦酸盐对体外小鼠颅骨破骨细胞数量和骨吸收的影响可以克服。除了甲羟戊酸。这些观察结果表明,含氮的双膦酸酯类药物在抑制诸如Ras之类的蛋白质的翻译后异戊二烯化后引起细胞凋亡。这些有效的抗吸收性双膦酸盐也可能通过阻止破骨细胞中的蛋白质异戊二烯来抑制骨吸收,甲羟戊酸途径的酶或异戊二烯基蛋白质转移酶是含氮双膦酸盐的分子靶标。此外,数据支持氯膦酸盐通过不同机制起作用的观点。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号